default author photo

Zhicheng Lai

Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China

SCHOLARLY PAPERS

2

DOWNLOADS

125

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Immune Checkpoint Inhibitors, Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib or Bevacizumab in Unresectable Hepatocellular Carcinoma: A Retrospective, Multi-Center, and Propensity Score Matching Study

Number of pages: 30 Posted: 16 Jul 2024
Zhicheng Lai, Yujie Xu, Hailong Chen, Anna Kan, Zichao Wu, Qijiong Li, Minqiang Lu, Wei Wei, Yao-Jun Zhang, Minshan Chen, Minke He, Xu Li and Ming Shi
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Guangzhou First People's Hospital, Guangzhou Medical University, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Guangzhou First People's Hospital, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 65 (924,743)

Abstract:

Loading...

Hepatocellular carcinoma, lenvatinib, bevacizumab, combination therapy, conversion resection

2.

Sorafenib Plus Hepatic Arterial Infusion Chemotherapy Versus Sorafenib Plus Transarterial Chemoembolization in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase 3 Trial (Shata-001 Study)

Number of pages: 34 Posted: 06 Apr 2025
Zhicheng Lai, Zefeng Du, Lichang Huang, Qijiong Li, Yexing Huang, Xu Li, Wei Wei, Yao-Jun Zhang, Minshan Chen, Ming Shi, Anna Kan and Minke He
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 60 (980,173)

Abstract:

Loading...

Hepatocellular carcinoma, sorafenib, transcatheter arterial chemoembolization, hepatic arterial infusion chemotherapy, biomolecular exploratory, phosphofructokinase